Post-earnings recap
Reported
Tue, Mar 25, 2025
EPS actual
$-0.18
EPS est.
$-0.12
EPS surprise
-53.85%
1-day move
-7.53%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Corvus Pharmaceuticals reported a loss that was worse than expected, leading to a significant drop in stock price by 7.53%. The lack of revenue data and management commentary adds uncertainty to the company's outlook. Investors may be concerned about the company's performance and future prospects given the disappointing EPS results.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.18 | N/A | -53.85% |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based solely on numerical results.